Page last updated: 2024-11-02

pioglitazone and Dry Eye

pioglitazone has been researched along with Dry Eye in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
"Dry eye was induced in 6-week-old female C57 mice."1.40Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice. ( Chen, Y; Li, B; Li, M; Sheng, M; Wang, W; Yang, L; Zhang, X, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y1
Zhang, X1
Yang, L1
Li, M1
Li, B1
Wang, W1
Sheng, M1

Other Studies

1 other study available for pioglitazone and Dry Eye

ArticleYear
Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice.
    Molecular medicine reports, 2014, Volume: 9, Issue:5

    Topics: Animals; Cell Count; Conjunctiva; Disease Models, Animal; Dry Eye Syndromes; Female; Gene Expression

2014